Flatiron Blog Informing global evidence strategies with real-world data across multiple geographies Published on January 29, 2026 By Arun Sujenthiran, MD SharePosted inReal-World EvidenceRegulatoryHTA and Market AccessLife sciencesReal-World Data More to exploreCan we trust AI-generated RWD? A systematic validation approach in prostate cancerReal-World EvidencePublicationsArtificial intelligenceData QualityReal-World DataWebinar: An HEOR playbook for oncology RWE and AI use to support European HTAReal-World EvidenceWebinarLife sciencesHEOR / RWEReal-World DataWhat we’ve learned from the first EU joint clinical assessments: Takeaways from a panel of RWE and HTA expertsReal-World EvidenceLife sciencesHEOR / RWEReal-World DataMultinational data
Can we trust AI-generated RWD? A systematic validation approach in prostate cancerReal-World EvidencePublicationsArtificial intelligenceData QualityReal-World Data
Webinar: An HEOR playbook for oncology RWE and AI use to support European HTAReal-World EvidenceWebinarLife sciencesHEOR / RWEReal-World Data
What we’ve learned from the first EU joint clinical assessments: Takeaways from a panel of RWE and HTA expertsReal-World EvidenceLife sciencesHEOR / RWEReal-World DataMultinational data
